Metropolitan Life Insurance Company (MetLife)’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,142
| Closed | -$1.16M | – | 2266 |
|
|
2021
Q4 | $1.16M | Sell |
7,142
-141
| -2% | -$22.7K | 0.02% | 869 |
|
|
2021
Q3 | $1.09M | Sell |
7,283
-238
| -3% | -$49.5K | 0.02% | 887 |
|
|
2021
Q2 | $1.84M | Sell |
7,521
-353
| -4% | -$92.6K | 0.03% | 566 |
|
|
2021
Q1 | $2.08M | Buy |
7,874
+197
| +3% | +$55.6K | 0.03% | 499 |
|
|
2020
Q4 | $2.25M | Sell |
7,677
-96
| -1% | -$24.6K | 0.03% | 433 |
|
|
2020
Q3 | $1.84M | Sell |
7,773
-355
| -4% | -$80.7K | 0.03% | 448 |
|
|
2020
Q2 | $1.61M | Sell |
8,128
-9,047
| -53% | -$1.69M | 0.03% | 487 |
|
|
2020
Q1 | $3.15M | Sell |
17,175
-637
| -4% | -$113K | 0.06% | 248 |
|
|
2019
Q4 | $2.97M | Sell |
17,812
-533
| -3% | -$79.3K | 0.05% | 343 |
|
|
2019
Q3 | $2.4M | Buy |
18,345
+1,815
| +11% | +$236K | 0.04% | 414 |
|
|
2019
Q2 | $2.01M | Buy |
16,530
+347
| +2% | +$41.2K | 0.03% | 521 |
|
|
2019
Q1 | $1.99M | Buy |
16,183
+7,480
| +86% | +$939K | 0.04% | 500 |
|
|
2018
Q4 | $1.02M | Buy |
8,703
+145
| +2% | +$17.1K | 0.02% | 800 |
|
|
2018
Q3 | $1.07M | Sell |
8,558
-724
| -8% | -$80K | 0.02% | 899 |
|
|
2018
Q2 | $793K | Buy |
9,282
+596
| +7% | +$43.8K | 0.01% | 1041 |
|
|
2018
Q1 | $524K | Sell |
8,686
-757
| -8% | -$43.1K | 0.01% | 1242 |
|
|
2017
Q4 | $498K | Sell |
9,443
-10,748
| -53% | -$566K | 0.01% | 1292 |
|
|
2017
Q3 | $1.13M | Hold |
20,191
| – | – | 0.01% | 1182 |
|
|
2017
Q2 | $1.27M | Hold |
20,191
| – | – | 0.01% | 1118 |
|
|
2017
Q1 | $1.03M | Hold |
20,191
| – | – | 0.01% | 1219 |
|
|
2016
Q4 | $861K | Hold |
20,191
| – | – | 0.01% | 1372 |
|
|
2016
Q3 | $958K | Sell |
20,191
-586
| -3% | -$29.2K | 0.01% | 1304 |
|
|
2016
Q2 | $1.05M | Sell |
20,777
-258
| -1% | -$13K | 0.01% | 1231 |
|
|
2016
Q1 | $1.02M | Buy |
21,035
+325
| +2% | +$12.5K | 0.01% | 1168 |
|
|
2015
Q4 | $814K | Hold |
20,710
| – | – | 0.01% | 1296 |
|
|
2015
Q3 | $786K | Hold |
20,710
| – | – | 0.01% | 1317 |
|
|
2015
Q2 | $823K | Sell |
20,710
-1,079
| -5% | -$33.6K | 0.01% | 1419 |
|
|
2015
Q1 | $584K | Hold |
21,789
| – | – | ﹤0.01% | 1477 |
|
|
2014
Q4 | $640K | Sell |
21,789
-730
| -3% | -$18K | ﹤0.01% | 1599 |
|
|
2014
Q3 | $454K | Sell |
22,519
-5,095
| -18% | -$98.3K | ﹤0.01% | 1776 |
|
|
2014
Q2 | $462K | Hold |
27,614
| – | – | ﹤0.01% | 1886 |
|
|
2014
Q1 | $411K | Hold |
27,614
| – | – | ﹤0.01% | 1949 |
|
|
2013
Q4 | $404K | Buy |
27,614
+298
| +1% | +$4.8K | ﹤0.01% | 1956 |
|
|
2013
Q3 | $470K | Sell |
27,316
-536
| -2% | -$7.95K | ﹤0.01% | 1794 |
|
|
2013
Q2 | $324K | Buy |
+27,852
| New | +$319K | ﹤0.01% | 1995 |
|
Other funds holding AMED
RP
Metropolitan Life Insurance Company (MetLife)'s AMED Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Amedisys (AMED) in Q1 2022, closing a stake of 7,142 shares — an estimated $1.16M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in AMED in Q2 2013 and held it in 35 quarters. The position peaked at $3.15M in Q1 2020. 329 funds tracked by Wall St. Rank hold AMED as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 7,142 Amedisys shares in Q1 2022, an estimated $1.16M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Amedisys in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Amedisys position peaked at $3.15M in Q1 2020.
- 329 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.